ELAVL3 Exacerbates Brain Injury and Cognitive Dysfunction in Mice After Cardiac Arrest by Increasing S100B mRNA Stability to Promote Microglia Activation
This study identifies the ELAVL3/S100B axis as a key driver of post-ischemic neuroinflammation and Targeting this pathway may offer a potential therapeutic strategy for cerebral ischemic injuries.
CD147 exacerbates ischemic brain injury and BBB disruption by suppressing neuronal Wnt/β-catenin signaling through a mechanism involving the AKT/GSK3β node, supporting further evaluation of CD147-directed interventions after stroke.
Yue-Qing Wang, F. Ogunleye, Chong-Lin Xu et al.· Scientific Reports· 0 citations
Microglia-targeted RIOK3 knockdown reduced infarct volume, improved early neurological and sensorimotor outcomes, preserved microglial process complexity, and reduced post-ischemic inflammation, and highlight the RIOK-YBX1 axis as a potential therapeutic target for ischemic stroke.
Yang Geng, Ningning Zong, Chao Zhou et al.· Experimental Neurology· 0 citations
BACKGROUND
Microglial ferroptosis is a key risk factor promoting neuroinflammation after ischemic brain injury (IBI). Although Compound 21 (C21) has neuroprotective and anti-inflammatory properties, its role in modulating microglial ferroptosis in IBI remains unexplored.
METHODS
IBI was induced in C57BL/6 mice via tr...
Yi-Jiu Wu, Xin-Qiang Zhou, Xu-Fang Huo et al.· Experimental Neurology· 0 citations
Microglial TREM1 represents a key therapeutic target, supporting the clinical application of HXF for ischemic stroke, and HXF alleviates neuroinflammation and neuronal pyroptosis by inhibiting microglial M1 polarization through the TREM1/DAP12 pathway.
Sedanolide alleviated CIRI by targeting STAT3 to inhibit microglial activation and pyroptosis, as evidenced by the decrease of neurological score, cerebral infarct volume, microglial activation markers and inflammatory factors.